Delivery Order SPE2DB22D2206-SPE2DB25FDP74

Award Date 10/4/24
Potential Completion Date 10/28/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,485.16 firm fixed price delivery order is for the supply of PROMACTA 50 MG TABLET, a specialty pharmaceutical product. The contract has an ultimate completion date of October 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $3,997.21 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET, a medication used to treat certain blood disorders. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,852.00 firm fixed price delivery order is for the supply of PROMACTA 75 mg tablets. The contract has an ultimate completion date of August 19, 2024 and was awarded on July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,485.16 firm fixed-price contract is for the supply of PROMACTA 50 MG TABLET, a drug product, with a performance period ending on August 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,991.63, is for the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 15, 2024. The contract is not designated as a set-aside, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,997.21 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET UU 30S, with an ultimate completion date of November 25, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation. The $10,852.00 firm-fixed-price delivery order is for the supply of PROMACTA 75 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,997.54 firm fixed-price delivery order is for the supply of PROMACTA 12.5 MG TABLET, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of November 25, 2024 and does not include any set-aside requirements. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award, valued at $8,834.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PROMACTA 12.5 MG TABLET medical supplies. The contract is a firm fixed-price delivery order with a completion date of February 5, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, with a ceiling value of $7,998.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROMACTA 12.5 mg tablets, a prescription medication, to support federal healthcare programs and facilities. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDP74
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 12.5 MG TABLET UU 30S. The $11,997.54 firm fixed-price delivery order has an ultimate completion date of October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 1/3/25, 9:25 AM